simvastatin has been researched along with Squamous Cell Carcinoma of Head and Neck in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Badiee, P; Berbeco, RI; Cheah, E; Dehghankelishadi, P; Dmochowska, N; Kempson, I; Maritz, MF; Thierry, B | 1 |
| Buchwald, ZS; Burnham, AJ; Kansal, V; Kinney, BLC; Lesinski, GB; Paulos, C; Saba, NF; Schmitt, NC | 1 |
| Kou, Y; Li, M; Liu, B; Liu, H; Rong, X; Wang, C; Yang, P; Zhang, Y; Zhou, Q | 1 |
| Gehrke, T; Hackenberg, S; Hagen, R; Ickrath, P; Kleinsasser, N; Schendzielorz, P; Scherzad, A | 1 |
| Baliga, M; Chakraborty, S; Kumari, T; Sarkar, S; Tusharbhai, DM | 1 |
| Aigner, A; Boehm, A; Dietz, A; Mozet, C; Stoehr, M; Wichmann, G | 1 |
6 other study(ies) available for simvastatin and Squamous Cell Carcinoma of Head and Neck
| Article | Year |
|---|---|
Formulation of simvastatin within high density lipoprotein enables potent tumour radiosensitisation.
Topics: Animals; Cholesterol, HDL; Head and Neck Neoplasms; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins, HDL; Mice; Simvastatin; Squamous Cell Carcinoma of Head and Neck | 2022 |
Statin drugs enhance responses to immune checkpoint blockade in head and neck cancer models.
Topics: Animals; Head and Neck Neoplasms; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immune Checkpoint Inhibitors; Lovastatin; Mice; Simvastatin; Squamous Cell Carcinoma of Head and Neck | 2023 |
Simvastatin inhibits proliferation and promotes apoptosis of oral squamous cell carcinoma through KLF2 signal.
Topics: Animals; Apoptosis; beta Catenin; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Head and Neck Neoplasms; Humans; Kruppel-Like Transcription Factors; Mice; Mouth Neoplasms; Simvastatin; Squamous Cell Carcinoma of Head and Neck | 2023 |
Additive antitumor effects of celecoxib and simvastatin on head and neck squamous cell carcinoma in vitro.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Squamous Cell; Celecoxib; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Synergism; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Interleukin-6; Interleukin-8; Simvastatin; Squamous Cell Carcinoma of Head and Neck | 2017 |
Is there a role for PRF with simvastatin in stage I osteoradionecrosis?
Topics: Debridement; Drug Therapy, Combination; Gels; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mandible; Middle Aged; Oropharyngeal Neoplasms; Osteoradionecrosis; Platelet-Rich Fibrin; Powders; Simvastatin; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome | 2018 |
Simvastatin suppresses head and neck squamous cell carcinoma ex vivo and enhances the cytostatic effects of chemotherapeutics.
Topics: Anticholesteremic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cell Line, Tumor; Cisplatin; Docetaxel; Dose-Response Relationship, Drug; Drug Synergism; Female; Head and Neck Neoplasms; Humans; KB Cells; Male; Neoplasm Staging; Risk Factors; Simvastatin; Squamous Cell Carcinoma of Head and Neck; Taxoids | 2014 |